Objective: To assess the main contributory factors on asthma control and on health-related quality of life in elderly asthmatic subjects.
polypharmacy are considered to be major reasons for worse control of asthma in older adults, no conclusive evidence exists to support these assumptions [7] and little is known about the combination of multiple chronic diseases with asthma in the elderly.
Comorbidities have an impact on the course of asthma, but also affect quality of life of patients [8, 9] . Quality of life is impaired in elderly people with a diagnosis of asthma [2, 9, 10] . The impairment may be influenced by age, asthma severity, duration of illness, socioeconomic conditions, somatic comorbidities and the presence of psychological factors such as anxiety and depression [2, [9] [10] [11] [12] [13] [14] [15] . In recent years, there has been increased interest in the subjective quality of life (QoL) of patients with bronchial asthma. QoL is a significant indicator guiding the efforts of professionals caring for patients, especially chronically ill ones. The identification of factors affecting the QoL reported by patients, despite their existing condition, is important and useful to provide multidisciplinary care for these patients. However, the perspective of the patient about asthma and its treatment in specific populations such as the elderly are poorly developed [16] .
The aim of our study was to assess the main contributory factors on asthma control and on healthrelated quality of life in elderly subjects.
Methods

Study subjects and collection of data
This was a retrospective case-control study nested in historical cohort data comparing patients who had partly controlled or uncontrolled asthma (ACT ≤ 19) (cases) with patients who had controlled asthma (ACT ≥ 20) (controls).
in the medical record), either spirometry with reversibility, defined as at least 12% and 200 mL increase in FEV 1 from baseline, diagnostic methacholine challenge or historical data of reversibility of FEV 1 after oral steroid trial and/or diffusion test in patient with persistent FEV 1 /FVC < 70 and/or FEV 1 < 80%. Current smokers were excluded. Patients unable to perform spirometry or without recent historical data of lung function were not included in the study.
The study protocol was reviewed and approved by the Ethics Committee of Hospital Universitario 12 de Octubre, Madrid (NºCEIC 14/175).
Assessments
We collected self-reported information about age of asthma onset, disease duration, severe asthma exacerbations in the previous year (defined as asthma exacerbations requiring emergency department visit and/or hospitalization) and comorbidities. Height and weight data were collected from medical records and Body Mass Index (BMI) was defined as weight divided by height squared, considering obesity for BMI ≥ 30.
Treatments received for longstanding asthma (short-acting β2-agonists, inhaled corticoids, long acting β2-agonists, combinations, and other treatments) were recorded. Daily dosage of inhaled corticosteroid was expressed as low, medium, or high doses according to GINA 2006 classification [17] . Medications adherence (self-reported compliance) and inhalation technique (evaluated by his/her doctor) were collected via their medical records. Atopic condition was assessed (at enrolment or historical data from medical records) by skin prick testing to a panel of common aeroallergens including pollens, moulds, house dust mite, and pets. A positive skin prick test was defined as a wheal at least 3 mm larger than the diameter of negative control. Asthma severity was classified following GINA 2006 determined by frequency of symptoms, night-time awakenings, short-acting β2-agonists use, interference with normal activity and lung function for patients who were not taking long-term control medications at time on enrolment or determined by lowest level of treatment required to maintain control in those taking long-term control medication [17] .
Pulmonary function was assessed with spirometry as a part of his/her routinely medical control according to the standardized technique [18] . Parameters of lung function such as forced vital 
Assessment scales
The ACT [20] is designed to measure asthma control without using pulmonary function values, with a cut-off point of ≥ 20 for the ACT score defining well controlled asthma, 16-19 for not well- 
Statistical analysis
A descriptive, bivariate and multivariate analysis was conducted in order to identify factors associated with asthma control and asthma related quality of life.
The data is expressed as mean and standard deviation [SD] , percentage (%) and 95% confidence interval where appropriate. The Chi-square test using cross table statistics, Mann-Whitney U tests or Student's t-test were used for comparison of two groups. The Kruskal-Wallis and ANOVA test were used for more than two independent groups with non-normal or normal distribution, respectively. Correlations between variables were calculated by Rho Spearman coefficient or R2
Pearson.
Multivariate analysis was performed using multiple linear regression for Asthma Quality of Life Questionnaire (total score and domains scores) as dependent variables and using logistic regression when poor control of asthma was analyzed as a dichotomous variable using as 
Results
Characteristics of population
We successfully evaluated 209 asthma patients (149 women and 60 men) aged 65 years and above. In the population studied, asthma was more common in women, mainly with intrinsic profile (non-allergic) and generally as a long-standing disease, with an onset in middle age of life. 
Asthma control and factors affecting asthma control
An ACT (Asthma control test) total score ≥ 20 (well controlled) was obtained in 145 patients (69%), 35 patients (16%) had 19-16 score (partly controlled) and 29 patients (13%) had ≤ 15 score (uncontrolled). According to ACT punctuation, we classified patients into 2 groups (cases and controls), where cases were 64 patients (30.62%) with partly controlled/uncontrolled asthma (ACT ≤ 19) and controls were patients with well controlled asthma (ACT ≥ 20) 145 (69.38%).
We have described main variables by level of asthma control (Table 2) . Analysing comparisons between groups, we did not find any statistically significant differences as a function of age, atopy, disease duration, lung function, asthma severity, Aspirin-Exacerbated Respiratory Disease (AERD) or comorbid conditions. We did find, however, significantly poorer asthma control in With regard to treatment, adherence was associated with asthma control (p 0.021), so correct adherence was more frequent in the well-controlled group. Anticholinergic treatment was more frequently prescribed in patients with partly/uncontrolled asthma (p 0.006). None patient was on specific immunotherapy at the moment of the study, but 42 (20.1%) had received in the past subcutaneous immunotherapy (when they were young or middle age), but it was not analyzed because of the great heterogeneity of the treatments. None patient was on biologic treatment.
In the score of AQLQ, both in the different domains and in the total score, partly/uncontrolled patients tend to have a higher score, which means greater impairment in quality of life.
In multivariate analysis of factors affecting asthma control measured by ACT (Table 3) (Table 4) .
Discussion
Suboptimal control of asthma has been reported in numerous studies [23, 24, 25] . In particular, in
Spain the rate of uncontrolled asthma according to the ACT score could reach up to 57.6% of patients [26] . Recently, the LIAISON study, one of the largest observational studies on characteristics and management of asthmatics in Europe, based on patient reported outcomes and using the Asthma Control Questionnaire (ACQ), confirmed rates of suboptimal control in 56.5 % of patients [27] .
Studies evaluating asthma control in the elderly are scarce but they coincided on one-third or more of elderly asthmatic patients having uncontrolled asthma. [29, 30] . Our findings indicate also that asthma control was suboptimal in one-third of older outpatients with asthma in a real-life study. This is a percentage lower than that observed in other age groups, but can be affected by being patient ongoing asthma treatment and followed-up at a tertiary care academic hospital for at least one year.
Comorbidities had been associated with poorly controlled asthma [4, 30] , and it is well known that older patients with asthma have an increased risk of comorbidities. Particularly some frequent comorbidities, such as chronic obstructive pulmonary disease, chronic sinusitis, obesity and depression are associated with uncontrolled asthma in elderly asthmatic patients [31] . Also, the number of comorbidities and polypharmacy have been linked with asthma control in the elderly [32, 33] . Although, recent studies demonstrated that in elderly asthmatics under specialist care, dysfunction were also associated with poor asthma control in the elderly [30] In general, there are important diagnostic challenges in asthma in the elderly, resulting from spirometric changes of ageing and similar clinical presentation of asthma, COPD and ACOS [1] . In our study, we exclude current smokers and those with persistent fixed airflow obstruction without normal diffusion test or an unequivocal asthma history at initial diagnosis in an attempt to exclude COPD patients, so we could not evaluate the influence of this comorbidity on asthma control score, but nevertheless, lung function did not modified asthma control score in our group of patients.
Previous findings showed that both a history of past asthma exacerbations and poor asthma control can increase the risk of future asthma exacerbations [35, 36] . Also, poorly or partly controlled asthma in elderly patients has been characterized by higher exacerbation rates [28] [29] [30] and an ACT score < 19 may be a significant predictor of asthma exacerbation in the following six months [33] .
Our results also observed an association between severe exacerbations in the last year and partly controlled/uncontrolled asthma in the past four week (OR 5.29) supporting that the ACT control test may be an important parameter for assessing risk of asthma exacerbations and healthcare resource consumption in elderly asthmatic patients.
Besides, good adherence is a predictor of asthma control [37] , also in the elderly [15] . With regard with this topic, we detected that lack of adherence was a predictor for poor asthma control (OR 8.33). However, in the analysis we used patient self-reported data about adherence that become very high and probably imprecise. Nevertheless, other authors also reported high rates of asthma treatment adherence in the elderly using more precise measures of compliance [33] .
In our work, asthma control and quality of life were directly related. Although comorbidities were not determinant for asthma control, the presence of some comorbidities like depression, GERD or osteoporosis were found to be associated to quality of life. The significant reduction in quality of life associated with comorbidity in asthma has been previously reported [8, 15] .
On the other hand, contrary to published by other authors [38], we do not detect relationship between quality of life and exacerbations. This can be due to the methodology used since exacerbations were collected during the last year, but the questionnaire of quality of life of Marks analyze a period fixed of the last four weeks.
Further, the quality of life perceived by patients directly affects the degree of control according to the ACT questionnaire, as has been previously observed [27] . In our opinion, the information contributed by both questionnaires is complementary, and in patients of this group of age they can help to take therapeutic decisions and to suspect the presence of depression. That is very important as depression is not only correlated to asthma control and quality of life but also is a predictor of To the best of the authors' knowledge, this is the first study in elderly subjects with asthma reporting main contributory factors on asthma control and health-related quality of life in Spanish population.
Some methodological limitations of the study should be mentioned. Patients were recruited from a tertiary hospital, which is likely to results in a group with a relatively severe asthma and frequent comorbidity. A complete psychological examination was not undergone and we did not use a specific geriatric assessment scale to determine depression and functional status; and adherence was not evaluated with an objective medication adherence measure or validated test.
In conclusion, most elderly asthmatic patients, even with severe or moderate persistent asthma, with comorbidities and long standing asthma, could achieve good control of asthma symptoms and normal lung function, but almost one-third had uncontrolled asthma despite receiving anti- 
